Expertise in
2
conditions

Daoquan Y. Peng

No. 139 Middle Renmin Road, 
Changsha, CN 
Expertise in
2
conditions
No. 139 Middle Renmin Road, 
Changsha, CN 

Overview

Daoquan Peng practices practicing medicine in Changsha, China.

Peng is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Hypertrophic Cardiomyopathy (HCM), Atherosclerosis, High Cholesterol, and Cardiomyopathy.

They are actively involved in clinical research, co-authoring 74 peer reviewed articles and participating in 1 clinical trial.

Locations

No. 139 Middle Renmin Road, Changsha, 410011, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel in Patients With Coronary Atherosclerotic Heart Disease and Planned Percutaneous Coronary Intervention: a Multi-center, Randomized, Double-blind, Triple-dummy , Parallel-controlled, Dose-exploration Phase II Trial
The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel in Patients With Coronary Atherosclerotic Heart Disease and Planned Percutaneous Coronary Intervention: a Multi-center, Randomized, Double-blind, Triple-dummy , Parallel-controlled, Dose-exploration Phase II Trial
Enrollment Status: Completed
Publish Date: September 23, 2019
Intervention Type: Drug
Study Phase: Phase 2

74 Total Publications

Long-Term Efficacy and Safety of Mavacamten in Chinese Patients With Obstructive Hypertrophic Cardiomyopathy: Week 78 Results From the EXPLORER-CN Study.
Long-Term Efficacy and Safety of Mavacamten in Chinese Patients With Obstructive Hypertrophic Cardiomyopathy: Week 78 Results From the EXPLORER-CN Study.
Journal: Journal of the American Heart Association
Published: May 25, 2026

Frequently Asked Questions about Daoquan Y. Peng

Is Daoquan Y. Peng a top-rated expert for Hypertrophic Cardiomyopathy (HCM)?

MediFind is an objective health platform that identifies experts based on real-world data. Daoquan Y. Peng is classified as an Advanced expert for Hypertrophic Cardiomyopathy (HCM), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Daoquan Y. Peng participate in research or clinical trials?

Yes. Daoquan Y. Peng has published 74 articles and abstracts on conditions like Hypertrophic Cardiomyopathy (HCM). You can view a list of Daoquan Y. Peng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Peng's expertise for a condition
ConditionClose
      View All 22 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile